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ECM = extracellular matrix; FAK = focal adhesion-associated tyrosine kinase; PTP = protein tyrosine phosphatase; RA = rheumatoid arthritis; SF =
synovial fibroblast; Src-PTK = src protein tyrosine kinase.
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Introduction
Fibronectin is an important component of the articular extra-
cellular matrix (ECM). Both fibronectin itself and fragments
of fibronectin bind to integrin receptors on mesenchymal
cells and exert a variety of effects. Of these, regulation of
cell growth, migration and survival are most prominent.
However, it has also been demonstrated that injection of
fibronectin fragments into joints may cause depletion of pro-
teoglycans [1] and induce the production of matrix degrad-
ing enzymes [2,3]. Binding of fibronectin to integrin
receptors results in the activation of tyrosine phosphoryla-
tion signals, and it is now accepted that the focal adhesion-
associated tyrosine kinase (FAK) plays a central role in this
process. Interactions of FAK with the src family of protein
tyrosine kinases (Src-PTKs) have been described as being
crucial for the initiation of signalling cascades that ultimately
mediate the effects of integrins. Despite this general
concept, early molecular events that regulate the associa-
tion of FAK with Src-PTKs and thus link integrin signalling to
cellular activation are unclear. Specifically, little is known
about the role of receptor protein tyrosine phosphatases
(PTPs), which have been implicated as positive and nega-
tive regulators of integrin signalling.
A recent report from Zeng and coworkers [4] sheds new
light on the involvement of PTPs in early integrin signalling.
Autophosphorylation of FAK at Tyr397 is a key initial step
in the formation of Src-PTK/FAK complexes, which in turn
mediate the phosphorylation of FAK associated proteins.
The establishment of this multi-phosphocomponent sig-
nalling complex appears to be regulated by several intra-
cellular PTPs, one of which is PTP-α. PTP-α can be found
in focal adhesions and is involved in the spreading of cells
on fibronectin. As shown in earlier studies, expression of
PTP-α correlates with Src-PTK activity, and PTP-α acts as
a physiological upstream regulator of Scr-PTKs [5].
Zheng and coworkers [4] compared wild-type, normal
PTP-α+/+ and PTP-α–/– mouse embryonic fibroblasts with
respect to their nonspecific cell migration as well as hap-
totactic migration toward fibronectin. In addition, they ana-
lyzed the effects of PTP-α on integrin-mediated FAK
phosphorylation. Those investigators observed abnormali-
ties of PTP-α–/– embryonic fibroblasts in migrating into
space on cell culture dishes. They showed that the migra-
tory defects of PTP-α–/– fibroblasts are associated with
altered cell morphology at the leading edge of migrating
cells. These changes are linked to reduced FAK Tyr397
phosphorylation during closure of artificial wounds. Their
finding that the haptotaxis of immortalized embryonic
fibroblasts to fibronectin critically depends on PTP-α is of
special interest. Fibronectin-induced rearrangement of the
cytoskeleton is retarded in PTP-α–/– cells, but reintroduc-
tion of PTP-α through adenoviral gene transfer partly
restores the migration of PTP-α–/– toward fibronectin.
Although no data on the expression of PTP-α following
gene transfer are presented, the authors suggest that the
lower levels of PTP-α protein in AdPTP-α transduced
PTP-α–/– fibroblasts as compared with wild-type PTP-α+/+
cells are responsible for the incomplete effects of adenovi-
ral delivery of PTP-α. Importantly, fibronectin-induced
association of FAK with Scr-PTKs is reduced also in
PTP-α–/– fibroblasts. The association of FAK with Src-
PTKs depends on the autophosphorylation status of FAK.
Therefore, the phosphorylation of FAK at Tyr397 in
PTP-α–/– fibroblasts was investigated; FAK Tyr397 phos-
phorylation in response to fibronectin-induced integrin
activation is impaired in the PTP-α–/– cells but can be
restored by expression of catalytically active PTP-α. Of
interest, the delay in cell spreading and the altered mor-
phology of PTP-α–/– cells were reproduced by addition of
Src-PTK inhibitors.
Based on these data, Zheng and coworkers concluded that
FAK Tyr397 phophorylation is an early event in integrin sig-
nalling and is mediated by PTP-α. Defects in PTP-α activity
result in the impaired formation of Src-PTK/FAK complexes
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and affect cytoskeletal rearrangement, cell spreading and
haptotaxis to ECM molecules. However, FAK interacts with
different members of Src-PTK family, and the precise nature
of these interactions requires further investigation. In addi-
tion, the question of how PTP-α acts as an Scr-PTK activa-
tor should now be addressed. Nevertheless, these data
highlight the role played by PTP-α as a key upstream regula-
tor of integrin-mediated signalling, linking ECM signals to
cell migration and Src-FAK signalling.
Integrin-mediated signal transduction is of considerable
interest in a variety of conditions that are associated with
altered attachment of fibroblasts-like cells to ECM. In
rheumatoid arthritis (RA), attachment of synovial fibroblast
to the ECM is an important initiating step in the progres-
sive destruction of articular cartilage [6]. Following early
morphological observations [7], several studies have
established the notion that the invasion of RA synovial
fibroblasts (SFs) into articular cartilage requires their
attachment to the cartilage surface. Integrins have been
identified as important receptors for ECM molecules in
RA, and the increased expression of integrins on RA-SFs
has been associated with their enhanced binding to ECM
[8]. Functional data support the concept that integrin-
mediated signalling events contribute to the invasiveness
of RA-SFs [9]. In addition, cartilage-specific fragments of
fibronectin have been identified as potent activators of
articular chondrocytes [3,10] and fibroblasts [11].
However, little is known about regulation of integrin sig-
nalling in RA-SFs and the relevance of Src-PTK/FAK for-
mation for synovial cell activation. This is in striking
contrast to the multitude of data illustrating the importance
of cytokine-mediated activation, as well as accumulating
evidence for stable alterations in the intracellular signalling
of RA-SFs. Thus, a recent study linked cytokine-mediated
expression of vascular cell adhesion molecule-1 in RA-SFs
to Src-dependent pathways [12], and data have been
reported that suggest that inhibition of Src-PTKs sup-
presses RA-SF proliferation and interleukin-6 production
[13]. In addition, PTEN, a tyrosine phosphatase that inter-
acts with FAK and negatively regulates integrin-mediated
cell spreading, is not expressed in RA-SFs of the most
superficial lining layer and at sites of invasion [14].
It is intriguing to speculate that alterations in Src-PTK/FAK
complex formation are present in RA-SFs, and it is clear
that this aspect of fibroblasts activation requires further
attention. By focusing on cytoskeletal rearrangement and
cell migration, Zeng and coworkers [4] address only part of
the several pathways that have been linked to Src and FAK
signalling and that are of interest for enhancing our under-
standing the complex nature of activated RA-SF behaviour.
This paper, together with data suggesting a role for Src-
FAK signalling in tumour cell metastasis [15], should stimu-
late studies focusing on the role of FAK-mediated
signalling, and specifically the role of PTPs, in RA-SFs.
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